Tag: news

  • WHO Reiterates Unscientific Stance Against Vaping

    WHO Reiterates Unscientific Stance Against Vaping

    While progress has been made in the fight against tobacco use, the marketing of e-cigarettes toward young people could have harmful health outcomes going forward, according to World Health Organization Director-General Tedros Adhanom Ghebreyesus.

    Ghebreyesus gave the warning in a statement along with the release of the “WHO report on the global tobacco epidemic 2021,” the eighth study from the United Nations public health agency measuring progress on efforts to curb the sale of tobacco and nicotine products worldwide.

    While the report found that more than four times as many people are covered under WHO-recommended tobacco control measures than in 2007, it expressed concern that children who use “electronic nicotine delivery systems, such as e-cigarettes, are “up to three times more likely to use tobacco products in the future.”

    “Nicotine is highly addictive. Electronic nicotine delivery systems are harmful, and must be better regulated,” Tedros said.

    He went on to argue that in places where e-cigarettes are not banned, “governments should adopt appropriate policies to protect their populations from the harms of electronic nicotine delivery systems, and to prevent their uptake by children, adolescents and other vulnerable groups.”

    Over 100 million ex-smokers use reduced-risk products and the WHO should be taking advantage of massive investment in the sector by encouraging governments to provide an incentivized regulatory framework to enable greater expansion.

    Tobacco harm reduction advocates and vaping industry representatives denounced the WHO report as “nonsensical and dangerous.”

    “The WHO has a long-standing anti-vaping stance and this latest attack on a sector that is literally saving millions of lives worldwide flies in the face of scientific evidence, common sense and harm reduction,” said John Dunne, director general of the U.K. Vaping Industry Association (UKVIA) in a statement.

    “This report demonstrates that, sadly, the WHO still doesn’t understand the fundamental difference between addiction to tobacco smoking, which kills millions of people every year, and addiction to nicotine, which doesn’t,” said John Britton, professor of epidemiology at University of Nottingham.

    “The WHO is also evidently still content with the hypocrisy of adopting a position which recommends the use of medicinal nicotine products to treat addiction to smoking, but advocates prohibition of consumer nicotine products which do the same thing, but better.”

    Derek Yach, president of the Foundation for a Smoke-Free World, said the WHO’s comments were “fundamentally flawed.” “The exceptional growth of next generation devices offers the WHO a real opportunity to tackle combustible consumption once and for all,” he said.

    “Over 100 million ex-smokers use reduced-risk products and the WHO should be taking advantage of massive investment in the sector by encouraging governments to provide an incentivized regulatory framework to enable greater expansion.”

    David Jones MP, who sits on the U.K. All Party Parliamentary Group for Smoking and Health, described the WHO’s opposition to all smoking alternatives, not just vaping, as “bizarre.”

    “Our advice remains that people who smoke are better to switch completely to vaping,” he said. “That opinion, however, is not shared by the WHO, which has long pursued an almost pathological campaign against e-cigarettes.”

  • Bidi Vapor Parent, Kaival Brands to Trade on NASDAQ

    Bidi Vapor Parent, Kaival Brands to Trade on NASDAQ

    Image: immimagery

    Kaival Brands Innovations Group, the exclusive global distributor of products manufactured by Bidi Vapor, has been approved to list the company’s common stock on the Nasdaq Capital Market. The ticker symbol will remain unchanged, as “KAVL,” and the stock will begin trading on Nasdaq at the opening of the market on July 29, 2021.

    “I am pleased to announce that the company has been approved to begin trading on Nasdaq,” said Niraj Patel, Kaival’s founder and CEO, in a statement. “This event represents another monumental milestone in our company’s short history.”

    “We have worked diligently to achieve this goal and are humbled and grateful on the inclusion to the Nasdaq,” said Patel. “We are more enthusiastic than ever about being able to harness Kaival’s exciting potential.”

    “Step by step, we continue our work to build a world-class, global organization—our elevation to Nasdaq represents a very large strategic evolution for the company,” noted Eric Mosser, chief operating officer of Kaival Brands.

  • Study: TikTok Must Age Restrict Access to Vape Videos

    Study: TikTok Must Age Restrict Access to Vape Videos

    A study of vaping videos on TikTok by Australian researchers found that there is an “urgent need” for age restrictions to reduce teens’ exposure to videos that positively portray vaping. University of Queensland researchers analysed e-cigarette content posted by TikTok users globally and are now calling for tighter regulations to prevent nicotine products being promoted to underage users of the video-sharing platform.

    Credit: Tashatuvango

    The study, published in the journal Tobacco Control, evaluated the content of 808 popular vaping videos that had been collectively viewed more than 1.5 billion times as of November 2020. The videos had a median count of 1 million views each, according to a story posted by The Guardian.

    The videos that portrayed e-cigarette use positively comprised 63 percent of the total and were viewed more than 1.1 billion times, while neutral depictions accounted for 24 percent. The researchers estimated that a quarter of the people in the videos appeared to be younger than 18, while 71 percent were male.

    “The use of comedy, lifestyle references, nicotine addiction references, vaping tricks and ‘how to’ tutorials may create social norms around vaping and increase its social acceptance,” the researchers concluded. “Considering vaping-related videos are widely accessible on TikTok, there is an urgent need to consider age restrictions to reduce youth uptake.”

    Tianze Sun, a PhD student at UQ and the study’s first author, said the researchers were interested in looking at how e-cigarette use was portrayed on TikTok, given the app’s popularity among young people. “Because it’s a relatively new platform, they also can potentially lack in regulations when it comes to effective age restrictions,” she said.

  • Arcus Compliance Appoints CBD Guru Robert Sidebottom

    Arcus Compliance Appoints CBD Guru Robert Sidebottom

    Photo: tadamichi

    Arcus Compliance appointed a new nonexecutive director, Robert Sidebottom.

    Sidebottom has broad commercial, management and board-level experience across the vape and CBD sectors. He is the group managing director for the Eco Vape Group of companies and was formerly the managing director for the vape compliance company Adact Medical.

    Sidebottom is a leading advocate of vaping, which he views as one of the essential tools in assisting smokers to quit traditional cigarettes. His commercial and compliance experience is underpinned by his qualifications and experience in project management, personnel management and finance.

    “I am thrilled to be joining the Arcus Compliance leadership team, and I look forward to contributing to their strategic direction and continuing the exponential growth as the prime compliance agency in the sector,” said Sidebottom in a UKVIA press note. “The Arcus board have set the correct tone of professionalism and customer service, and I am very happy to have the opportunity to work with them.”

    “We are thrilled to have Robert on board,” said Lee Bryan, managing director of Arcus Compliance. “He will be working closely with our other directors and in particular our other [nonexecutive director,] John Dunne. Prior to his appointment and for the last 12 months, Robert and I have discussed how we can improve vaping compliance, with the aim of making products as safe as possible for the vaping community and switching smokers to the 95 percent safer alternative of vaping.”

    Arcus Compliance has enjoyed rapid growth over the last 18 months and has significantly increased its market share within the SaaS space in the electronic nicotine-delivery systems (ENDS) and vape product sector. Arcus Compliance is currently regarded as the leading regulatory consultancy in Europe for ENDS products and boasts a client base of many of the world’s leading brands.

  • U.S. Lawmakers Introduce Bill to Require Vapor User Fees

    U.S. Lawmakers Introduce Bill to Require Vapor User Fees

    Six U.S. senators have introduced legislation that would require e-cigarette manufacturers pay user fees to the Food and Drug Administration (FDA) to provide the regulatory agency. The fees would finance additional resources for the FDA to conduct stronger oversight of the e-cigarette industry and increase awareness of the danger of e-cigarettes.

    U.S. Senate Majority Whip Dick Durbin joined U.S. Senators Jeanne Shaheen, Lisa Murkowski, Susan Collins, Tammy Baldwin, and Mitt Romney introduced the Resources to Prevent Youth Vaping Act to protect children from the dangers of e-cigarettes, according to press release from Durbin’s office. Companion legislation will be introduced in the House by U.S. Representatives Cheri Bustos and Brian Fitzpatrick.

    Credit: Larry

    “Big Vape has hooked nearly four million kids on e-cigarettes, creating a vaping epidemic that is threatening our next generation with a lifetime of nicotine addiction and disease,” said Durbin. “The FDA needs to clear the shelves of these dangerous and addictive products, and Congress needs to pass the Resources to Prevent Youth Vaping Act, which will help provide FDA with the resources to better regulate this market.  Enough is enough. The health of our children cannot wait any longer.”

    The Resources to Prevent Youth Vaping Act increases the total amount that will be collected in tobacco user fees by $100 million in Fiscal Year (FY) 2022 and indexes that amount to inflation for future years. The bill also authorizes FDA to collect user fees from all manufacturers of products that have been deemed as tobacco products by FDA, including e-cigarettes, according to Durbin.

    Currently, manufacturers of traditional combustible tobacco products pay into FDA user fees, but e-cigarette companies are exempt due to a loophole in the law. The amount collected from individual e-cigarette manufacturers will be proportional to their share of the overall tobacco market, as determined by FDA. FDA would be able to use this additional revenue from e-cigarette user fees to conduct safety review of vaping products, prevent sales of e-cigarettes to minors, help support efforts to educate youth on the dangers of e-cigarettes and increase the agency’s oversight and enforcement capabilities.  

    Earlier this year, Durbin introduced the bicameral Tobacco Tax Equity Act to reduce youth tobacco use by closing loopholes in the tax code that have long been exploited by the tobacco industry to avoid regulation and taxes for their products. The bill would also apply tax parity across all tobacco products, including establishing the first federal e-cigarette tax and increased the tobacco tax rate for the first time in a decade.

  • Group: UK COP9 Delegation Must Support Science

    Group: UK COP9 Delegation Must Support Science

    A parliamentary group in the U.K. has released a report that criticizes anti-vaping groups funded by Bloomberg Philanthropies for being hostile to tobacco harm reduction (THR). The report also states that Bloomberg diminishes the rights of consumers and vapers in low and middle-income countries (LMICs) such as the Philippines.

    Credit: Olrat

    The UK’s All-Party Parliamentary Group for Vaping (APPG) said these anti-vaping “civil society observers” will be allowed to participate in the World Health Organization Framework Convention on Tobacco Control Conference of the Parties 9 (FCTC COP 9) in November this year, concluding that the WHO continues to attempt to discredit UK’s science and policy approach to address the smoking problem, reports the Manila Bulletin. It said THR is a public health approach which is supposedly one of the original commitments of FCTC.

    The APPG warned about the participation of The Union, a group funded by Bloomberg Philanthropies, as well as other anti-vaping non-government organizations in the FCTC COP 9 meeting in November. The APPG is asking the UK delegation to the FCTC COP9 meeting to ensure that its national experience and real-life evidence/data are reflected in the discussions within the WHO.

    The APPG also wanted to ensure that the WHO would not move away from the fundamental objectives set forth by the FCTC given its original commitment to harm reduction—a public health approach being opposed by some influential non-government organizations. “The majority of NGOs listed as ‘Observers’ are hostile to the concept of tobacco harm reduction and thus the UK’s policy approach. For instance, ‘The Union’ has advocated a complete ban on e-cigarettes and heated tobacco products in low and middle-income countries, which are home to 80 percent of the world’s smokers,” the APPG said in the report.

  • Next Generation Labs Nixes Patent Agreement with Kaival

    Next Generation Labs Nixes Patent Agreement with Kaival

    Photo: sorapop

    Next Generation Labs, which manufactures and markets bulk R-S, R- and S-isomer synthetic nicotine under its TFN brand, has terminated its Sept. 28, 2020, patent contribution agreement with Kaival Brands Innovation Group and Kaival Labs.

    The Patent Contribution Agreement related to the acquisition and commercial exploitation by Kaival of Next Generation Labs’ IP portfolio on combinational use of synthetic R- and S-isomer nicotine ratios in tobacco cessation products.

    In a press note, Next Generation Labs said Kaival Labs had published inaccurate and misleading statements relating to the use of patented synthetic nicotine for tobacco cessation products on its website. “Next Generation Labs wants to clarify that as a consequence of Kaival’s failure to perform its obligations under the Patent Contribution Agreement, all rights to the R-S synthetic nicotine cessation patent portfolio fully reverted to Next Generation Labs in May 2021,” Next Generation Labs wrote.

    Additionally, Kaival executed a confirmatory transfer agreement with Next Generation Labs relinquishing all rights to the Next Generation Labs patent portfolio for the commercialization of combinational TFN R-S nicotine relating to tobacco cessation products. Kaival is not an authorized agent of Next Generation Labs, nor is it authorized to use Next Generation Labs’ name, intellectual property or its TFN trademark on its products, in its product marketing or in any financial prospectus to investors, according to Next Generation Labs.

  • Juul Labs Class Action Inches Closer to Trial

    Juul Labs Class Action Inches Closer to Trial

    Photo: steheap

    An expansive class action lawsuit against Juul Labs inched closer to trail when a federal judge advanced conspiracy and fraud claims against the company’s founders, board members and biggest investor, Altria Group, reports Court House News Service.

    On July 22, U.S. District Judge William Orrick III refused to dismiss the bulk of claims filed by 19 plaintiffs in 14 states. The suit accuses Juul and its leaders of intentionally using deceptive ads and marketing campaigns to get young people hooked on vaping to create a new generation of nicotine addicts.

    The plaintiffs say Juul failed to warn consumers that its e-cigarette products were highly addictive and that the company falsely claimed in ads and labels that its prefilled pods contained 5 percent nicotine, the same amount in a pack of cigarettes, when the pods contained much higher levels. They also say Juul fraudulently marketed its vaping products as a “safer alternative” to combustible cigarette smoking.

    The plaintiffs seek to hold Juul and Altria Group, liable for fraud, negligence, negligent misrepresentation, strict product liability and medical monitoring.

    Judge Orrick rejected requests by Juul founders and top executives James Monsees and Adam Bowen to dismiss the claims against them, finding the plaintiffs “adequately alleged that both Monsees and Bowen engaged in acts that had the intent and impact of misleading the public and plaintiffs about the dangers of Juul.”

    Orrick also rejected Altria’s motion to dismiss, citing meetings that occurred between Altria and Juul in California regarding the development of “business agreements and arrangements through which Altria supported [Juul]’s manufacturing, regulatory, marketing, and distribution efforts and how Altria’s efforts through [Juul] in California achieved their common goals.”

    Orrick found many of the arguments made by Altria and Juul’s founders and directors cannot be adequately evaluated until a later stage of litigation when more evidence is available for a jury or judge to scrutinize.

  • Heating Products Exempted from Mexico ENDS Ban

    Heating Products Exempted from Mexico ENDS Ban

    Photo: niyazz

    Mexico’s Supreme Court has ruled that heated tobacco products (HTP) will be exempted from a February 2020 presidential decree that bans importation of electronic nicotine delivery systems (ENDS), reports Filter.

    Prior to the on July 16 ruling, manufacturers were able to import and sell HTPs legally using a loophole in the law called “habeas corpus trials.” But the loophole prevented the development of a fully regulated, legal market. The new presidential decree reverses that and allows for increased sales of these devices.

    Vapor products that use e-liquids continue to be banned by the Mexican government. According to Roberto Sussman, a researcher at the National University of Mexico and president of Pro-Vapeo Mexico, the vapor market in Mexico has been functioning since 2009 as part of the huge informal economy, which employs more than 50 percent of the workforce and it is illegal but not criminal.

    It was an embarrassment for President Andrés Manuel López Obrador, who has expressed opposition to foreign NGOs and agents meddling with Mexican government regulations.

    More than 1.2 million Mexicans—1 percent of the adult population—use vapor products somewhat regularly, according to a survey by the Global State of Tobacco Harm Reduction.

    According to Filter, a fatal blow to the HTP ban came when it was leaked that the draft of the decree was written by a lawyer working for the Campaign for Tobacco-Free Kids.

    “It was an embarrassment for President Andrés Manuel López Obrador, who has expressed opposition to foreign NGOs and agents meddling with Mexican government regulations,” said Roberto Sussman.

    It’s not the first time Mexico’s Supreme Court intervened in the country’s drug policy. On June 28, it stepped in to legalize marijuana, after lawmakers had failed to finalize the legislation the court demanded three years earlier.

  • Australian Patent for Next Generation’s Synthetic Nicotine

    Australian Patent for Next Generation’s Synthetic Nicotine

    Image: Zerbor

    Next Generation Labs has received an Australian patent for its innovative use of combinational ratios of synthetic R- and S-isomer nicotine in tobacco cessation products.

    “This patent gives Next Generation Labs additional IP protection as the company pursues its international effort to encourage the adoption and use of novel synthetic combinational R-S isomer nicotine, to assist consumers in their desire to break away from tobacco use and their long-term dependence to the reportedly highly addictive S-isomer nicotine,” the company wrote in a statement.

    Next Generation Labs started producing bulk synthetic nicotine in 2014, at a time when there was no commercial availability of isolated R- and S-isomer nicotine. Given that both isomers can be produced in abundance by Next Generation Labs at relatively low cost, industry partners can now access separated isomers for commercialization into products that may aid cessation, enhance quit success rates and moderate overall tobacco use, according to the company.

    “Next Generation Labs believes future combinational R- and S-isomer nicotine formulations may prove to be less addictive than natural or biosimilar standalone S-isomer nicotine, and could potentially help achieve the broader public health goal of providing adult consumers with a satisfying, but non-addictive form of nicotine to replace current products,” the company wrote. “These new variable isomeric ratios of synthetic nicotine products may ultimately assist adults in quitting or reducing their overall dependence on current tobacco, vape and nicotine products that deliver only the purported highly addictive ‘S’ form of nicotine.”

    The granting of the Australian TFN R-S nicotine cessation patent is in addition to existing Next Generation Labs patents that have been issued in China, South Korea, Japan, Canada, Europe and the United States.